Clinical Trial Update: Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells [Phase 1, Phase 2]

View source ↗

Summary

Update indicating completion of Phase 1/2 clinical trials evaluating bone marrow mononuclear cells for severe adult traumatic brain injury. The sponsor is The U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: COMPLETED